MONTREAL, Oct. 31 /CNW Telbec/ - Biophage Pharma (TSX-V: BUG), a
biopharmaceutical company focused on the development and commercialization of
innovative phage-based technologies for the detection and management of
bacterial contaminations, reported today its financial results for the third
quarter ended August 31, 2006.
